about Neurofounders

Exploring the frontier between neuroscience, startups, and translational research.
Neurofounders is an independent editorial platform dedicated to advancing public understanding of neurotechnology. Founded to bring clarity to a fast-moving and often over-hyped field, Neurofounders focuses on the science, systems, and people shaping how brain technologies are developed, regulated, and deployed.

Why Neurofounders? Because the future of brain technology will not be built by breakthroughs alone, but by the founders, researchers, clinicians, engineers, and institutions that turn ideas into real-world systems. Our goal is to illuminate that process.

Our reporting covers brain-computer interfaces, neuromodulation, neuroimaging, consumer neurotech, cognitive and mental-health technologies, and the tools and infrastructure that support them. While mainstream technology and health media often focus on consumer products, funding headlines, or speculative futures, Neurofounders concentrates on the deeper layers of the neurotech stack: measurement, clinical translation, regulation, and long-term impact. We aim to complement existing coverage by providing context, continuity, and technical depth.

Much of our work sits at the intersection of science, industry, and policy. We translate academic research into accessible insight, examine emerging companies beyond press releases, and explore how regulation and ethics are shaping the trajectory of neurotechnology. Storytelling is central to our approach, but never at the expense of accuracy. Precision matters in a field where claims can easily outpace evidence.

Neurofounders operates with editorial independence. Our content is not influenced by sponsors, investors, institutions, or companies covered. Editorial decisions are made solely on the basis of relevance, rigor, and reader value. When commercial partnerships or sponsored content appear, they are clearly disclosed and separated from independent reporting.

Beyond journalism, Neurofounders is building an open resource layer for the neurotech ecosystem, including company maps, glossaries, reports, and market intelligence. These tools are designed to support founders, researchers, investors, and policymakers navigating a rapidly evolving field.

Neurotechnology is moving from the lab into clinics, products, and everyday life. Neurofounders exists to help make sense of that transition.

Thank you for reading. We invite you to explore the site, engage with the work, and follow along as the neurotech landscape continues to unfold.

Meet the Neurofounders Team

Dominic Borkelmans

Editor-in-chief

Dominic Borkelmans is the founder and editor-in-chief of Neurofounders. His work focuses on early-stage neurotechnology companies, clinical and regulatory developments, and the translation of neuroscience into deployable technologies. He holds an MSc in Applied Neuroscience from King’s College London and an MSc in Entrepreneurship from Esade Business School, and works with companies and researchers across the neurotech ecosystem.

Romane Mirasson

Guest Writer

Romane Mirasson is a guest writer at Neurofounders, where she writes about early-stage developments in psychiatry and mental health. Alongside her editorial work, she brings three years of experience in life science consulting. Romane holds an MPhil in Bioscience Enterprise from the University of Cambridge and graduate and postgraduate degrees in Neuroscience from UCL

Victoria Shi

Guest Writer

Victoria Shi is a biomedical engineer and neurotechnology researcher passionate about turning science into real-world impact. She has worked across research and startup settings, including UCSF, Clarity, and her own medtech venture TENSible, and is completing her master’s in Bioinnovation in Neuroscience at ESPCI Paris-PSL.

Jemima Lowe

Guest Writer

Jemima Lowe is a guest writer, focusing on the intersection of brain health, technology, and human behavior. Her work centres on innovation and research in real-world neuro-technological applications. Alongside this, she works as Innovation Lead at the Jameel Arts & Health Lab, holds an MSc in Behavioural Science from the London School of Economics (LSE), and collaborates with researchers and partners across the neurotech and global health space.